Trial Profile
A randomized clinical trial of delirium prevention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 15 Jul 2017 Status changed from recruiting to completed.
- 24 Nov 2016 Planned number of patients changed from 200 to 70.
- 18 May 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.